Discussing the diagnosis of HPV-OSCC: common questions and answers - Wikidata - wikimedia - TriplyDB

Discussing the diagnosis of HPV-OSCC: common questions and answers

Discussing the diagnosis of HPV-OSCC: common questions and answers

http://www.wikidata.org/entity/Q27000693

about

Epidemiologic trends in head and neck cancer and aids in diagnosis Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign.Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link - A Systematic Review.Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners The role of sexual behavior in head and neck cancer: implications for prevention and therapy.Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.Human Papillomavirus Vaccination Counseling in Pediatric Training: Are We Discussing Otolaryngology-Related Manifestations?Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.

P2860

Q26852167-D7E13415-4FBD-4A20-A3F9-1A5B07B77CBD Q30248794-644CD143-3419-4F38-93C9-63FCF44BD46B Q30251750-D88623EB-2F1F-4321-BA9D-53B08EB9EDCF Q34682692-88E7277E-965E-48DD-8490-4A92D12D3EBA Q35272050-CB93F2F9-039B-4C2A-B89E-2D5DA20669C5 Q36218314-1CC6FEAF-F85D-4866-AAEE-C569E58B5143 Q36970051-D178EDBA-4170-41DA-AF41-C6F1DDA06F7D Q37275499-0CFDC441-97F7-4D7A-B36D-7F959A48D17F Q40306831-88ADECD7-52A7-4C27-928E-812AE0678D0F Q40333822-3A49397A-4902-4974-9643-71D0323DF114 Q40736348-426B5975-B64B-475F-B46D-2DF93ADE13A6 Q42214756-151DC341-F162-4320-8B76-6EE891268C1A Q47563578-4633DB16-9C3D-45A9-876B-B5939976C4AB

P2860

Discussing the diagnosis of HPV-OSCC: common questions and answers

http://www.wikidata.org/entity/Q27000693

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Discussing the diagnosis of HPV-OSCC: common questions and answers

@ast

Discussing the diagnosis of HPV-OSCC: common questions and answers

@en

Discussing the diagnosis of HPV-OSCC: common questions and answers

@nl

type

label

Discussing the diagnosis of HPV-OSCC: common questions and answers

@ast

Discussing the diagnosis of HPV-OSCC: common questions and answers

@en

Discussing the diagnosis of HPV-OSCC: common questions and answers

@nl

prefLabel

Discussing the diagnosis of HPV-OSCC: common questions and answers

@ast

Discussing the diagnosis of HPV-OSCC: common questions and answers

@en

Discussing the diagnosis of HPV-OSCC: common questions and answers

@nl

P1433

Q27000693-73BD3373-3B39-4020-A114-43FB7150DB12

P1476

Q27000693-FC23257E-936C-483F-B312-BE159C0A5181

P2093

Q27000693-9DBF2756-8934-4B7B-BF16-4AC1236D88E3

Q27000693-B0AFF54A-23A8-4A2D-82D1-9187EA9C9591

P2860

Q27000693-0219F2E3-CC37-43DE-9541-F3D0DA2C4B9B

Q27000693-05BD86AF-A5FC-44C6-BE4E-028931CDF313

Q27000693-06B2FFDD-105D-4364-871A-53DF6929F3A4

Q27000693-0C3ACA79-C9BD-4E17-8D2A-BBC65D91DB0A

Q27000693-0CA72487-0CCB-49E7-A636-BA196477FAD9

Q27000693-13B9BB69-3F2B-463A-B680-248399AAD15A

Q27000693-146619C0-96D2-4F75-939D-E1D5E48CEF52

Q27000693-1507E68A-B298-46CD-B646-71DE48D84A8B

Q27000693-1BCEB412-DA12-4398-B1E5-6AEE17C61F1A

Q27000693-2079D21B-80B2-4FDF-B7FA-4E42B90B7F3E

P304

Q27000693-A0CF1362-D4CD-438D-BC02-D6621068AF40

P31

Q27000693-19390771-0F03-4052-B83D-360A610E6EBD

P3181

Q27000693-D294F0AC-59F2-4856-A8C4-A3C4023D9E1F

P356

Q27000693-7615C08E-70E0-4B97-906E-94C39F7ADAB0

P407

Q27000693-1F0112D4-DA9D-4795-AE68-76295442D35E

P433

Q27000693-65A0548D-EA59-4625-8E88-B8CA9E9C0147

P478

Q27000693-AC63CACD-BFA7-457B-9318-0FBB559135BD

P577

Q27000693-DF18CDEA-B94C-4D67-B57A-0CA15A8D3FD6

P698

Q27000693-28D99333-3949-472F-90EB-0E0343C771B7

P932

Q27000693-496D111C-AE63-4116-A944-D06508F16FEA

P3181

P356

J.ORALONCOLOGY.2013.06.002

P1433

P1476

Discussing the diagnosis of HPV-OSCC: common questions and answers

@en

P2093

Carole Fakhry

http://www.w3.org/2001/XMLSchema#string

Gypsyamber D’Souza

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

The role of HPV in head and neck cancer and review of the HPV vaccine

Effect of providing information about normal test results on patients' reassurance: randomised controlled trial

Human papillomavirus and survival of patients with oropharyngeal cancer.

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Condom use and the risk of genital human papillomavirus infection in young women

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)

Case-control study of human papillomavirus and oropharyngeal cancer

P304

863-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1672084

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.ORALONCOLOGY.2013.06.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23876627

http://www.w3.org/2001/XMLSchema#string

P932

4264664

http://www.w3.org/2001/XMLSchema#string